Placental Aromatase Deficiency

Overview

Aromatase deficiency is an autosomal recessive disorder in which there is decrease or absence in the level of aromatase in the body which leads to impairment in conversion of androgens to estrogen. This is due to a genetic mutation in the CYP19A1 , a subtype of [P450]. Patient affected by this disease typically presents with maternal virilization ,amenorrhea in puberty in females. Males are rarely affected.

Historical Perspective

The evidence of the disease goes back to year 1991, when the first case of aromatase deficiency occurred. Most of the cases were that of women during the third trimester of pregnancy presenting with maternal virilization resulting in hirsutism and acne.

Pathophysiology

CYP19A1 gene is responsible for the production of enzyme aromatase, which converts androgens to different forms of estrogen . Estrogen is involved in sexual development in females prior to birth and the levels peak during pregnancy. Mutation in CYP19A1 gene leads to deficiency or absence of activity of aromatase. As a result, there is decrease in production of estrogen due to lack of conversion of androgens to estrogen and increase in testosterone and androstenedione levels. In pregnant women , excess androgens cross the placenta and enter into the maternal circulation leading to virilization. Female fetuses who are affected have ambiguous genitalia while males develop osteoporosis.